York Capital Management Global Advisors, LLC Humacyte, Inc. Transaction History

York Capital Management Global Advisors, LLC

$81.4 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$1.22 - $5.14 $1.09 Million - $4.58 Million	-891,973 Reduced 38.93%	1,399,424 $4.56 Million
Q3 2021 Nov 15, 2021	BUY	$9.21 - $16.99 $21.1 Million - $38.9 Million	2,291,397 New	2,291,397 $20.6 Million

Others Institutions Holding HUMA

# of Institutions

150

Shares Held

35.1M

Call Options Held

279K

Put Options Held

607K

Black Rock Inc. New York, NY

7.14M
Shares

$33.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$23.5 Million
0.0% of portfolio
State Street Corp Boston, MA

4.76M
Shares

$22.1 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

2.04M
Shares

$9.47 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.27M
Shares

$5.88 Million
0.0% of portfolio

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $478M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of York Capital Management Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on York Capital Management Global Advisors, LLC with notifications on news.

Account